Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma

Varkaris, Andreas MD1,2,3; Lewis, David W MD4; Nugent, Francis W MD5

American Journal of Gastroenterology: December 2017 - Volume 112 - Issue 12 - p 1895–1896
doi: 10.1038/ajg.2017.387

1Department of General Internal Medicine, Lahey Clinic, Burlington, Massachusetts, USA

2TUFTS Medical School, TUFTS University, Boston, Massachusetts, USA

3Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece

4Hepatobiliary Surgery and Liver Transplantation, Lahey Medical Center, Burlington, Massachusetts, USA

5Department of Oncology, Lahey Clinic, Burlington, Massachusetts, USA

Correspondence: Andreas Varkaris, MD, Department of General Internal Medicine, Lahey Clinic, 41 Mall Road, Burlington, Massachusetts 01803, USA. E-mail:

The authors declare no conflict of interest.

© The American College of Gastroenterology 2017. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website